Search clinical trials for: Lu-177 DOTATATE (Lutathera®)
Total 234 results
-
Ralph NULL SalloumChildren's Hospital Medical Center, CincinnatiRecruitingHigh Grade Glioma | Medulloblastoma | Meningioma | Anaplastic Ependymoma | Recurrent Malignant Glioma | Recurrent Medulloblastoma | Refractory Malignant Glioma | Refractory Medulloblastoma | Recurrent Diffuse Intrinsic Pontine Glioma | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary... and other conditionsUnited States
-
University College, LondonNot yet recruitingMedullary Thyroid Carcinoma | Bronchial and Thymic Neuroendocrine Tumour | Paraganglioma/ Phaeochromocytoma | Those Requiring Repeat Peptide Receptor Radionuclide Therapy
-
Novartis PharmaceuticalsCompletedNeuroendocrine TumorUnited States
-
Advanced Accelerator ApplicationsActive, not recruitingNeuroendocrine TumorsUnited Kingdom, Portugal, Spain, France, United States
-
University of IowaNovartisNot yet recruitingNeuroendocrine Tumors | Neuroendocrine Tumor Grade 2 | Neuroendocrine Tumor Grade 1United States
-
Marnix LamCompletedNeuroendocrine Tumors | Liver MetastasesNetherlands
-
OHSU Knight Cancer InstituteNovartis; Oregon Health and Science UniversityNot yet recruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMetastatic Adrenal Gland Pheochromocytoma | Stage III Thyroid Gland Medullary Carcinoma AJCC v8 | Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 | Locally Advanced Adrenal Gland Pheochromocytoma | Locally Advanced Paraganglioma | Metastatic Paraganglioma | Metastatic Parathyroid Gland Carcinoma and other conditionsUnited States
-
Advanced Accelerator ApplicationsActive, not recruitingGastroenteropancreatic Neuroendocrine TumorItaly
-
David BushnellNational Cancer Institute (NCI); National Institutes of Health (NIH); Progenics...WithdrawnNeuroendocrine Tumors | Gastro-enteropancreatic Neuroendocrine TumorUnited States
-
Providence Health & ServicesExelixis; Advanced Accelerator Applications SAActive, not recruitingNeuroendocrine TumorsUnited States
-
Erasmus Medical CenterRecruitingNeuroendocrine TumorsNetherlands
-
NYU Langone HealthRecruitingMeningiomaUnited States
-
Institut du Cancer de Montpellier - Val d'AurelleRecruitingProgressive Disease | Neuroendocrine Tumors | Intestinal Well Differentiated Endocrine TumorFrance
-
Imperial College LondonNot yet recruiting
-
King's College Hospital NHS TrustAdvanced Accelerator ApplicationsNot yet recruitingCarcinoid Tumor | Carcinoid Syndrome | Carcinoid Heart Disease
-
Novartis PharmaceuticalsActive, not recruitingSomatostatin Receptor-positive GEP-NETKorea, Republic of
-
Imperial College LondonAdvanced Accelerator Applications International SARecruiting
-
University Health Network, TorontoCancer Care Ontario; Ozmosis Research Inc.; Canadian Molecular Imaging Probe...Active, not recruitingNeuroendocrine TumorsCanada
-
Sociedad Española de Medicina Nuclear e Imagen...RecruitingDigestive System Diseases | Neoplasms | Neoplasms by Histologic Type | Neoplasms by Site | Endocrine System Diseases | Stomach Neoplasms | Gastrointestinal Neoplasms | Digestive System Neoplasms | Neoplasms, Germ Cell and Embryonal | Endocrine Gland Neoplasms | Neuroectodermal Tumors | Neoplasms, Nerve Tissue | Intestinal Diseases and other conditionsSpain
-
Advanced Accelerator ApplicationsActive, not recruitingPheochromocytoma | Paraganglioma | Gastroenteropancreatic Neuroendocrine TumorsUnited States, Spain, France, Poland, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingSomatostatin Receptor-positive Neuroendocrine TumorJapan
-
University of Wisconsin, MadisonNot yet recruitingNeuroendocrine Tumors | Somatostatin Receptor-positive Neuroendocrine TumorUnited States
-
Advanced Accelerator ApplicationsApproved for marketingNeuroendocrine TumorsUnited States
-
Sue O'DorisioAdvanced Accelerator ApplicationsWithdrawnNeuroendocrine Tumors | Pheochromocytoma | ParagangliomaUnited States
-
Stanford UniversityNovartis PharmaceuticalsRecruitingGastroenteropancreatic Neuroendocrine TumorUnited States
-
Weill Medical College of Cornell UniversityMerck Sharp & Dohme LLC; Novartis; GI Research FoundationRecruitingMerkel Cell CarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Metastatic Prostate Small Cell Neuroendocrine Carcinoma | Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation | Metastatic Prostate Neuroendocrine CarcinomaUnited States
-
AHS Cancer Control AlbertaRecruitingCarcinoma, NeuroendocrineCanada
-
IRCCS San RaffaeleCompletedNeuroendocrine TumorsItaly
-
Melanoma and Skin Cancer Trials LimitedRecruitingMetastatic Merkel Cell CarcinomaAustralia
-
Lawson Health Research InstituteActive, not recruiting
-
Jakob StenmanNovartis; Advanced Accelerator ApplicationsRecruitingNeuroblastoma | Neuroblastoma RecurrentSweden, Denmark, Lithuania, Norway, Netherlands
-
Ebrahim S DelpassandExcel Diagnostics and Nuclear Oncology CenterCompletedNeuroendocrine TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingNeuroendocrine Tumors | Liver-Dominant Metastatic Pancreatic Neuroendocrine TumorsUnited States
-
Institut Claudius RegaudAdvanced Accelerator ApplicationsRecruiting
-
Advanced Accelerator ApplicationsActive, not recruitingGastro-enteropancreatic Neuroendocrine TumorSpain, United States, United Kingdom, France, Canada, Germany, Netherlands, Italy, Korea, Republic of
-
Peking UniversityUnknownNeuroendocrine TumorsChina
-
National Cancer Institute (NCI)RecruitingMetastatic Midgut Neuroendocrine Tumor | Unresectable Midgut Neuroendocrine Tumor | Metastatic Midgut Neuroendocrine Tumor G1 | Metastatic Midgut Neuroendocrine Tumor G2United States, Canada
-
Vanderbilt-Ingram Cancer CenterRecruitingMetastatic Digestive System Neuroendocrine Neoplasm | Metastatic Malignant Neoplasm in the Liver | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2 | Digestive System Neuroendocrine Tumor G1 | Digestive System Neuroendocrine Tumor G2United States
-
Istituto Scientifico Romagnolo per lo Studio e...Istituto Europeo di Oncologia IEO MILANOActive, not recruitingNeuroendocrine Tumors | Gastro Entero Pancreatic Neuroendocrine TumorsItaly
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Digestive System Neuroendocrine Neoplasm | Metastatic Neuroendocrine TumorUnited States
-
National Cancer Institute (NCI)Recruiting
-
Tine Gregersen, MDRecruitingNeuroendocrine NeoplasmDenmark
-
Novartis PharmaceuticalsRecruitingGlioblastomaSpain, Switzerland, France, Portugal, United States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingMetastatic Pancreatic Neuroendocrine Tumor | Unresectable Pancreatic Neuroendocrine CarcinomaUnited States
-
Istituto Scientifico Romagnolo per lo Studio e...Active, not recruiting
-
National Cancer Institute (NCI)Active, not recruiting
-
CHU de Quebec-Universite LavalRecruitingNeuroendocrine Tumors | Carcinoma, Neuroendocrine | Carcinoid TumorCanada
-
University of ChicagoRecruitingPancreas Cancer | Pancreatic Neuroendocrine TumorUnited States